Canaccord Genuity Group Boosts Anpario (LON:ANP) Price Target to GBX 370

Anpario (LON:ANPFree Report) had its price target increased by Canaccord Genuity Group from GBX 340 ($4.49) to GBX 370 ($4.89) in a research report report published on Wednesday, MarketBeat Ratings reports. Canaccord Genuity Group currently has a buy rating on the stock.

Separately, Shore Capital reaffirmed a house stock rating on shares of Anpario in a research report on Wednesday, September 11th.

Get Our Latest Stock Analysis on ANP

Anpario Price Performance

ANP stock opened at GBX 312.50 ($4.13) on Wednesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 5.16 and a current ratio of 5.13. Anpario has a fifty-two week low of GBX 220 ($2.91) and a fifty-two week high of GBX 340 ($4.49). The stock’s 50 day simple moving average is GBX 288.36 and its 200 day simple moving average is GBX 274.23. The company has a market cap of £52.84 million, a P/E ratio of 1,736.11 and a beta of 0.57.

Anpario Cuts Dividend

The firm also recently announced a dividend, which will be paid on Friday, November 29th. Investors of record on Thursday, November 14th will be issued a GBX 3.25 ($0.04) dividend. The ex-dividend date of this dividend is Thursday, November 14th. This represents a dividend yield of 1.19%. Anpario’s dividend payout ratio is presently 6,111.11%.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, produces and distributes natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Recommended Stories

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.